Literature DB >> 12629068

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.

Anat Ben-Shlomo1, Shlomo Melmed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12629068     DOI： 10.1210/jc.2002-020072

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

Review 1.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  Somatostatin agonists for treatment of acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Mol Cell Endocrinol       Date:  2007-11-29       Impact factor: 4.102

Review 3.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

4.  The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein in Pichia pastoris.

Authors:  Yuedi Ding; Jun Fan; Wenxin Li; Ying Peng; Runlin Yang; Lili Deng; Qiang Fu
Journal:  J Ind Microbiol Biotechnol       Date:  2014-04-22       Impact factor: 3.346

Review 5.  Acromegaly.

Authors:  Massimo Scacchi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 6.  Medical therapy: options and uses.

Authors:  John D Carmichael; Vivien S Bonert
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

7.  Diagnosis and treatment of acromegaly complications.

Authors:  A Giustina; F F Casanueva; F Cavagnini; P Chanson; D Clemmons; L A Frohman; R Gaillard; K Ho; P Jaquet; D L Kleinberg; S W J Lamberts; G Lombardi; M Sheppard; C J Strasburger; M L Vance; J A H Wass; S Melmed
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 8.  Octreotide long-acting release (LAR): a review of its use in the management of acromegaly.

Authors:  Kate McKeage; Susan Cheer; Antona J Wagstaff
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Nanomedicines in the treatment of acromegaly: focus on pegvisomant.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes Romijn
Journal:  Int J Nanomedicine       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.